Cargando…

Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma

BACKGROUND: Glioblastoma multiforme (GBM) is extensively genetically and transcriptionally heterogeneous, which poses challenges for classification and management. Long noncoding RNAs (lncRNAs) play a critical role in the development and progression of GBM, especially in tumor-associated immune proc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Wanli, Ma, Yanan, Hou, Wenbin, Wang, Fang, Cheng, Wan, Qiu, Feng, Wu, Pengfei, Zhang, Guohua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657607/ https://www.ncbi.nlm.nih.gov/pubmed/34899682 http://dx.doi.org/10.3389/fimmu.2021.706936

Ejemplares similares

Computational identification of immune-related lncRNA signature for predicting the prognosis and immune landscape of human glioblastoma multiforme
por: Shi, Dongjie, et al.
Publicado: (2022)

Identification of an epithelial-mesenchymal transition-related lncRNA prognostic signature for patients with glioblastoma
por: Yang, XinJie, et al.
Publicado: (2021)

Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer
por: Wu, Zhiwei, et al.
Publicado: (2022)

Identification and validation of ferroptosis-related lncRNA signature as a prognostic model for skin cutaneous melanoma
por: Guo, Sen, et al.
Publicado: (2022)

Systematic identification of lncRNA-based prognostic biomarkers for glioblastoma
por: Li, Mingdong, et al.
Publicado: (2019)

Identification of Molecular Subtypes and a Prognostic Signature Based on Inflammation-Related Genes in Colon Adenocarcinoma
por: Qiu, Chenjie, et al.
Publicado: (2021)

A novel prognostic related lncRNA signature associated with amino acid metabolism in glioma
por: Lei, Qiang, et al.
Publicado: (2023)

Identification and Validation of 17-lncRNA Related to Regulatory T Cell Heterogeneity as a Prognostic Signature for Head and Neck Squamous Cell Carcinoma
por: Sun, Qi, et al.
Publicado: (2021)

Establishment of a lncRNA-Based Prognostic Gene Signature Associated With Altered Immune Responses in HCC
por: Li, Xiawei, et al.
Publicado: (2022)

Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma
por: Liu, Binfeng, et al.
Publicado: (2022)

A Five Immune-Related lncRNA Signature as a Prognostic Target for Glioblastoma
por: Li, Xiaomeng, et al.
Publicado: (2021)

Identification of Prognostic Signature of Necroptosis-Related lncRNAs and Molecular Subtypes in Glioma
por: Zhang, Guanghao, et al.
Publicado: (2022)

Identification of pyroptosis-related lncRNA subtype and signature predicts the prognosis in bladder cancer
por: Zeng, Tao, et al.
Publicado: (2023)

Six-lncRNA Immune Prognostic Signature for Cervical Cancer
por: Chen, Qian, et al.
Publicado: (2020)

Identification of m6A- and ferroptosis-related lncRNA signature for predicting immune efficacy in hepatocellular carcinoma
por: Xie, Hongjun, et al.
Publicado: (2022)

A novel cuproptosis-related prognostic lncRNA signature for predicting immune and drug therapy response in hepatocellular carcinoma
por: Chen, Shujia, et al.
Publicado: (2022)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

Identification and validation of immune‐related lncRNA prognostic signatures for melanoma
por: Xiao, Bo, et al.
Publicado: (2021)

Identification of a Six-lncRNA Signature With Prognostic Value for Breast Cancer Patients
por: Zhao, Erjie, et al.
Publicado: (2020)

Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration
por: Wang, Zhengguang, et al.
Publicado: (2022)

Characterization and validation of a ferroptosis-related LncRNA signature as a novel prognostic model for lung adenocarcinoma in tumor microenvironment
por: Wang, Yuanyong, et al.
Publicado: (2022)

Identification and validation of a five-lncRNA prognostic signature related to Glioma using bioinformatics analysis
por: Zhang, Chunyu, et al.
Publicado: (2021)

Identification and characterization of lncRNA mediated transcriptional dysregulation dictates lncRNA roles in glioblastoma
por: Li, Yongsheng, et al.
Publicado: (2016)

Identification and validation of stemness-related lncRNA prognostic signature for breast cancer
por: Li, Xiaoying, et al.
Publicado: (2020)

Identification of the 3-lncRNA Signature as a Prognostic Biomarker for Colorectal Cancer
por: Liu, Shuzhen, et al.
Publicado: (2020)

Identification and Validation of EMT-Related lncRNA Prognostic Signature for Colorectal Cancer
por: Li, Danfeng, et al.
Publicado: (2021)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021)

Identification of LncRNA Prognostic Signature Associated With Genomic Instability in Pancreatic Adenocarcinoma
por: Zhu, Jinfeng, et al.
Publicado: (2022)

Identification of a novel lncRNA prognostic signature and analysis of functional lncRNA AC115619.1 in hepatocellular carcinoma
por: Gan, Binliang, et al.
Publicado: (2023)

Identification of CD4(+) Conventional T Cells-Related lncRNA Signature to Improve the Prediction of Prognosis and Immunotherapy Response in Breast Cancer
por: Ning, Shipeng, et al.
Publicado: (2022)

Development of a novel hypoxia-immune–related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer
por: Luan, Likun, et al.
Publicado: (2022)

A Six-lncRNA Signature for Immunophenotype Prediction of Glioblastoma Multiforme
por: Gao, Ming, et al.
Publicado: (2021)

Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma
por: Xiao, Junbo, et al.
Publicado: (2022)

Transcriptome profiling-based identification of prognostic subtypes and multi-omics signatures of glioblastoma
por: Park, Junseong, et al.
Publicado: (2019)

A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA
por: Yang, Mingyi, et al.
Publicado: (2022)

Identification of Methylation Immune Subtypes and Establishment of a Prognostic Signature for Gliomas Using Immune-Related Genes
por: Hu, Zhengang, et al.
Publicado: (2021)

Identification and validation of a prognostic immune-related lncRNA signature in bladder cancer
por: Zhao, Kai, et al.
Publicado: (2021)

Identification of the 7-lncRNA Signature as a Prognostic Biomarker for Acute Myeloid Leukemia
por: Liu, Chun-yu, et al.
Publicado: (2021)

Identification of a Two-lncRNA Signature with Prognostic and Diagnostic Value for Hepatocellular Carcinoma
por: Liu, Huiying, et al.
Publicado: (2022)

The cox-filter method identifies respective subtype-specific lncRNA prognostic signatures for two human cancers
por: Tian, Suyan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4mfcsdbg3jf23d5ro4tso7digl